Otofarma SpA (MIL:OTO) LT-Debt-to-Total-Asset: 0.13 (As of Dec. 2024)


MIL:OTO Otofarma SpA MIL:OTO
16 GF Score
Price €2.80
! 1 Warning Sign
View Full Analysis

What is Otofarma SpA LT-Debt-to-Total-Asset?

Otofarma SpA MIL:OTO -0.71% 16 LT-Debt-to-Total-Asset is 0.13 as of Dec. 2024. GuruFocus rates MIL:OTO with a GF Score™ of 16/100. The stock has 1 warning sign investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Otofarma SpA's long-term debt to total assests ratio for the quarter that ended in Dec. 2024 was 0.13.

Otofarma SpA's long-term debt to total assets ratio increased from . 20 (0.00) to Dec. 2024 (0.13). It may suggest that Otofarma SpA is progressively becoming more dependent on debt to grow their business.

Otofarma SpA  (MIL:OTO) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Otofarma SpA LT-Debt-to-Total-Asset Related Terms

Otofarma SpA LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Otofarma SpA's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Otofarma SpA LT-Debt-to-Total-Asset Chart

Otofarma SpA Annual Data
Trend Dec23 Dec24
LT-Debt-to-Total-Asset
0.12 0.13

Otofarma SpA Semi-Annual Data
Dec23 Dec24
LT-Debt-to-Total-Asset 0.12 0.13
MIL:OTO
16GF Score
Otofarma SpA MIL:OTO
LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Otofarma SpA LT-Debt-to-Total-Asset Calculation

Otofarma SpA's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2024 is calculated as

LT Debt to Total Assets (A: Dec. 2024 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2024 )/Total Assets (A: Dec. 2024 )
=1.306/10.183
=0.13

Otofarma SpA's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2024 is calculated as

LT Debt to Total Assets (Q: Dec. 2024 )=Long-Term Debt & Capital Lease Obligation (Q: Dec. 2024 )/Total Assets (Q: Dec. 2024 )
=1.306/10.183
=0.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.13 mean?
Otofarma SpA (MIL:OTO) has a LT-Debt-to-Total-Asset of 0.13 as of Dec. 2024. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Otofarma SpA and its competitors.
Is Otofarma SpA's LT-Debt-to-Total-Asset too high?
Otofarma SpA's current LT-Debt-to-Total-Asset is 0.13. Overall, Otofarma SpA has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Otofarma SpA's LT-Debt-to-Total-Asset compare to ABT and SYK?
Otofarma SpA's LT-Debt-to-Total-Asset of 0.13 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Medical Devices & Instruments company?
A good LT-Debt-to-Total-Asset depends on the Medical Devices & Instruments industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Otofarma SpA and its competitors. Otofarma SpA's current LT-Debt-to-Total-Asset is 0.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Otofarma SpA stock overvalued right now?
Otofarma SpA (MIL:OTO) has a current LT-Debt-to-Total-Asset of 0.13. The current LT-Debt-to-Total-Asset is 0.13. Otofarma SpA's overall GF Score™ is 16/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Otofarma SpA (MIL:OTO), the current LT-Debt-to-Total-Asset is 0.13 as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Otofarma SpA Business Description

Address Ripuaria Way, 50k, Marina di Varcaturo, Naples, ITA, 80014
Otofarma SpA is engaged in the construction and production of hearing aids, is constantly growing in the audiological field to provide adequate responses to every type of hearing aid need to its customers who require the possible personalized application of custom-made hearing aids. It provides otoacoustic medical devices and TELEMEDICINE services exclusively in affiliated pharmacies, possessing a portfolio of Instrumental IT patents.
16GF Score

Get the complete analysis for MIL:OTO

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.80
Price